Patents by Inventor Haizhen MO

Haizhen MO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Application of a hydrogel in the preparation of products for the treatment of bacterial infections
    Patent number: 11957712
    Abstract: An application of a hydrogel in the preparation of products for the treatment of bacterial infection is disclosed. Ferrous ion was used in the antibacterial activity test of Staphylococcus aureus and showed a strong bactericidal effect, which the survival rate of Staphylococcus aureus is less than 0.001%, as well as the survival rate of methicillin-resistant Staphylococcus aureus (MRSA) was less than 0.01%. Ferrous ion hydrogel was used for the treatment of keratitis and skin wound infection. Ferrous ion hydrogel for the treatment of keratitis and skin wound infection, which can significantly reduce the risk of pulmonary MRSA infection, prevented the dissimilation of MRSA to the lung, and alleviated systemic inflammation in the body in a timely and effective manner, revealing the therapeutic potential of ferrous compounds for treatment of Staphylococcus aureus infections, including MRSA.
    Type: Grant
    Filed: April 19, 2023
    Date of Patent: April 16, 2024
    Assignee: SHAANXI UNIVERSITY OF SCIENCE & TECHNOLOGY
    Inventors: Liangbin Hu, Haizhen Mo, Xiaohui Zhou, Hongbo Li, Dan Xu, Zhenbin Liu, Zhen Wang
  • APPLICATION OF A HYDROGEL IN THE PREPARATION OF PRODUCTS FOR THE TREATMENT OF BACTERIAL INFECTIONS
    Publication number: 20230338418
    Abstract: An application of a hydrogel in the preparation of products for the treatment of bacterial infection is disclosed. Ferrous ion was used in the antibacterial activity test of Staphylococcus aureus and showed a strong bactericidal effect, which the survival rate of Staphylococcus aureus is less than 0.001%, as well as the survival rate of methicillin-resistant Staphylococcus aureus (MRSA) was less than 0.01%. Ferrous ion hydrogel was used for the treatment of keratitis and skin wound infection. Ferrous ion hydrogel for the treatment of keratitis and skin wound infection, which can significantly reduce the risk of pulmonary MRSA infection, prevented the dissimilation of MRSA to the lung, and alleviated systemic inflammation in the body in a timely and effective manner, revealing the therapeutic potential of ferrous compounds for treatment of Staphylococcus aureus infections, including MRSA.
    Type: Application
    Filed: April 19, 2023
    Publication date: October 26, 2023
    Applicant: Shaanxi University of Science & Technology
    Inventors: Liangbin HU, Haizhen MO, Xiaohui ZHOU, Hongbo LI, Dan XU, Zhenbin LIU, Zhen WANG